Skip to content

Drug interactions

Indacaterol-glycopyrronium + Levodopa

Severity: Minor

Indacaterol-glycopyrronium and Levodopa: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Inhaled glycopyrronium has limited systemic exposure, so the interaction with levodopa is minor. Systemic anticholinergics may delay gastric emptying and reduce levodopa absorption, and can worsen dyskinesia.

What this interaction means in plain words

Indacaterol-glycopyrronium and Levodopa have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Indacaterol-glycopyrronium belongs to Respiratory; Levodopa belongs to Central Nervous System.

Evidence level: Low

Why it happens

Antimuscarinic slowing of gastric emptying may reduce levodopa absorption, with pharmacodynamic effects on motor symptoms.

What to do

No routine action needed; reassess motor control if parkinsonian symptoms or dyskinesia change after starting.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Levodopa, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Levodopa?

MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Levodopa have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Inhaled glycopyrronium has limited systemic exposure, so the interaction with levodopa is minor. Systemic anticholinergics may delay gastric emptying and reduce levodopa absorption, and can worsen dyskinesia.

How serious is the interaction between Indacaterol-glycopyrronium and Levodopa?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action needed; reassess motor control if parkinsonian symptoms or dyskinesia change after starting.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in